Comment on ‘Anaphylaxis caused by in‐season switchover of sublingual immunotherapy formulation’

Publisher: John Wiley & Sons Inc

E-ISSN: 1399-3038|26|1|92-92

ISSN: 0905-6157

Source: PEDIATRIC ALLERGY AND IMMUNOLOGY, Vol.26, Iss.1, 2015-02, pp. : 92-92

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract